243 related articles for article (PubMed ID: 8612059)
1. Neurobehavioral aspects of the pharmacotherapy of alcohol dependence.
Anton RF; Kranzler HR; Meyer RE
Clin Neurosci; 1995; 3(3):145-54. PubMed ID: 8612059
[TBL] [Abstract][Full Text] [Related]
2. Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment.
Volpicelli JR; Volpicelli LA; O'Brien CP
Alcohol Alcohol; 1995 Nov; 30(6):789-98. PubMed ID: 8679021
[TBL] [Abstract][Full Text] [Related]
3. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism.
Glanz J; Grant B; Monteiro M; Tabakoff B;
Alcohol Clin Exp Res; 2002 Jul; 26(7):1047-61. PubMed ID: 12170115
[TBL] [Abstract][Full Text] [Related]
4. A rational approach to the pharmacotherapy of alcohol dependence.
Petrakis IL
J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S3-12. PubMed ID: 17114952
[TBL] [Abstract][Full Text] [Related]
5. Advances in the use of naltrexone: an integration of preclinical and clinical findings.
O'Malley SS; Froehlich JC
Recent Dev Alcohol; 2003; 16():217-45. PubMed ID: 12638640
[TBL] [Abstract][Full Text] [Related]
6. The pharmacological treatment of alcoholism: from basic science to clinical medicine.
Verbanck PM
Alcohol Alcohol; 1995 Nov; 30(6):757-64. PubMed ID: 8679016
[TBL] [Abstract][Full Text] [Related]
7. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
8. Neurobiology and treatment in alcoholism--recent findings regarding Lesch's typology of alcohol dependence.
Hillemacher T; Bleich S
Alcohol Alcohol; 2008; 43(3):341-6. PubMed ID: 18339813
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in alcoholism:opioid peptides.
Froehlich JC; Li TK
Recent Dev Alcohol; 1993; 11():187-205. PubMed ID: 7901877
[TBL] [Abstract][Full Text] [Related]
10. Long-acting injectable naltrexone for the treatment of alcohol dependence.
Mannelli P; Peindl K; Masand PS; Patkar AA
Expert Rev Neurother; 2007 Oct; 7(10):1265-77. PubMed ID: 17939765
[TBL] [Abstract][Full Text] [Related]
11. Drugs for relapse prevention of alcoholism: ten years of progress.
Spanagel R; Kiefer F
Trends Pharmacol Sci; 2008 Mar; 29(3):109-15. PubMed ID: 18262663
[TBL] [Abstract][Full Text] [Related]
12. Biobehavioural basis of pharmacologic treatment of alcohol dependence.
Sellers EM
Alcohol Alcohol Suppl; 1994; 2():517-21. PubMed ID: 8974377
[TBL] [Abstract][Full Text] [Related]
13. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
[TBL] [Abstract][Full Text] [Related]
14. The alcohol-preferring P rat and animal models of excessive alcohol drinking.
Bell RL; Rodd ZA; Lumeng L; Murphy JM; McBride WJ
Addict Biol; 2006 Sep; 11(3-4):270-88. PubMed ID: 16961759
[TBL] [Abstract][Full Text] [Related]
15. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
[TBL] [Abstract][Full Text] [Related]
16. Combining psychosocial treatment with pharmacotherapy for alcohol dependence.
Weiss RD; Kueppenbender KD
J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S37-42. PubMed ID: 17114954
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone in the treatment of alcohol dependence: a Canadian trial.
Romach MK; Sellers EM; Somer GR; Landry M; Cunningham GM; Jovey RD; McKay C; Boislard J; Mercier C; Pépin JM; Perreault J; Lemire E; Baker RP; Campbell W; Ryan D
Can J Clin Pharmacol; 2002; 9(3):130-6. PubMed ID: 12422250
[TBL] [Abstract][Full Text] [Related]
18. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse.
O'Malley SS
Alcohol Alcohol; 1996 Mar; 31 Suppl 1():77-81. PubMed ID: 8737005
[TBL] [Abstract][Full Text] [Related]
19. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
Hungund BL; Basavarajappa BS
Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
[TBL] [Abstract][Full Text] [Related]
20. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
Simpson TL; Saxon AJ; Meredith CW; Malte CA; McBride B; Ferguson LC; Gross CA; Hart KL; Raskind M
Alcohol Clin Exp Res; 2009 Feb; 33(2):255-63. PubMed ID: 18945226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
